Researcher Profile Statistics: Xiaomeng Wang
Geo Map
Region
#
AS - Asia, other
259
NA - North America
51
EU - Europe
8
SA - South America
1
Total
319
Country
#
SG - Singapore
229
US - United States of America
51
CN - China
15
HK - Hong Kong
14
DE - Germany
4
AT - Austria
2
BR - Brazil
1
FR - France
1
IE - Ireland
1
MY - Malaysia
1
Total
319
City
#
Singapore
221
Ashburn
15
Hong Kong
12
Shanghai
10
Heilbronn
4
Santa Clara
4
Boardman
3
San Marcos
3
Beijing
2
Shenzhen
2
other
43
Total
319
Most viewed items
#
ID: 240403 - Lrg1 promotes metastatic dissemination of melanoma through regulating egfr/stat3 signalling
161
Total: {0}
161
Most type viewed
#
ID: other -
0
ID: journal -
319
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
319
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2022
0 0
0 0 0 0
0 0 0 19
13 14
46
2023
1 13
16 10 14 22
12 14 14 10
17 14
157
2024
15 11
14 19 14 11
18 10 4 0
0 0
116
Ever
319
Geo Map
Region | # |
---|---|
AS - Asia, other | 259 |
NA - North America | 51 |
EU - Europe | 8 |
SA - South America | 1 |
Total | 319 |
Country | # |
---|---|
SG - Singapore | 229 |
US - United States of America | 51 |
CN - China | 15 |
HK - Hong Kong | 14 |
DE - Germany | 4 |
AT - Austria | 2 |
BR - Brazil | 1 |
FR - France | 1 |
IE - Ireland | 1 |
MY - Malaysia | 1 |
Total | 319 |
City | # |
---|---|
Singapore | 221 |
Ashburn | 15 |
Hong Kong | 12 |
Shanghai | 10 |
Heilbronn | 4 |
Santa Clara | 4 |
Boardman | 3 |
San Marcos | 3 |
Beijing | 2 |
Shenzhen | 2 |
other | 43 |
Total | 319 |
Most viewed items | # |
---|---|
ID: 240403 - Lrg1 promotes metastatic dissemination of melanoma through regulating egfr/stat3 signalling | 161 |
Total: {0} | 161 |
Most type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 319 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: allItems - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 319 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 | 13 | 14 | 46 |
2023 | 1 | 13 | 16 | 10 | 14 | 22 | 12 | 14 | 14 | 10 | 17 | 14 | 157 |
2024 | 15 | 11 | 14 | 19 | 14 | 11 | 18 | 10 | 4 | 0 | 0 | 0 | 116 |
Ever | 319 |